⌘K

Home/Filings/4/0001213900-20-007661

4//SEC Filing

Breski Yaron 4

Accession 0001213900-20-007661

CIK 0001739174other

View on SEC.gov Company Profile

Filed

Mar 26, 8:00 PM ET

Accepted

Mar 27, 4:00 PM ET

Size

5.4 KB

Accession

0001213900-20-007661

Insider Transaction Report

Form 4

Period: 2020-03-25

Director

Transactions

Award
Common Stock Options - Right to Buy
2020-03-25+16,000→ 16,000 total
Exercise: $6.21Exp: 2030-03-25→ Common Stock (16,000 underlying)

Footnotes (1)

[F1]The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 25, 2021, and the remainder vesting in 12 equal quarterly installments over three years.

Documents

1 file

4
ownership.xmlPrimary

Issuer

BiomX Inc.

CIK 0001739174

Entity typeother

Related Parties

1

filerCIK 0001792673

Filing Metadata

Form type: 4
Filed: Mar 26, 8:00 PM ET
Accepted: Mar 27, 4:00 PM ET
Size: 5.4 KB

View on SEC.gov